Beyond the Low Frequency Fluctuations: Morning and Evening Differences in Human Brain

Abstract

Human performance, alertness, and most biological functions express rhythmic fluctuations across a 24-h-period. This phenomenon is believed to originate from differences in both circadian and homeostatic sleep-wake regulatory processes. Interactions between these processes result in time-of-day modulations of behavioral performance as well as brain activity patterns. Although the basic mechanism of the 24-h clock is conserved across evolution, there are interindividual differences in the timing of sleep-wake cycles, subjective alertness and functioning throughout the day. The study of circadian typology differences has increased during the last few years, especially research on extreme chronotypes, which provide a unique way to investigate the effects of sleep-wake regulation on cerebral mechanisms. Using functional magnetic resonance imaging (fMRI), we assessed the influence of chronotype and time-of-day on resting-state functional connectivity. Twenty-nine extreme morning- and 34 evening-type participants underwent two fMRI sessions: about 1 h after wake-up time (morning) and about 10 h after wake-up time (evening), scheduled according to their declared habitual sleep-wake pattern on a regular working day. Analysis of obtained neuroimaging data disclosed only an effect of time of day on resting-state functional connectivity; there were different patterns of functional connectivity between morning (MS) and evening (ES) sessions. The results of our study showed no differences between extreme morning-type and evening-type individuals. We demonstrate that circadian and homeostatic influences on the resting-state functional connectivity have a universal character, unaffected by circadian typology.

Oxytocin modulates local topography of human functional connectome in healthy men at rest

“…This protocol maintained double-blinding while avoiding the potential washing-out of intranasally deposited oxytocin (as might have been the case if oxytocin had been administered at the first treatment administration point and placebo at the third administration point). All sessions were conducted during the morning to minimise potential circadian variability in resting brain activity 79 or oxytocin levels 80 .

Fig.

…”

Reliability of BOLD signals in chronic stroke‐induced aphasia

“…In addition to increasing the duration of individual scans, repeated scans across multiple visits may help eliminate noise caused by normal day-to-day intrasubject variance in things like arousal, mood, and motivation. Although not accounted for in the present study, recent evidence has suggested that circadian (Fafrowicz et al, 2019) and hormonal (Arélin et al, 2015;Goldstein et al, 2005) cycles may impact fMRI measures, possibly pointing to value in considering the timing of sequential visits. A wide range of drugs may also impact BOLD variability, such as those which affect blood pressure (Wang et al, 2006), psychoactive medications such as antidepressants (Delaveau et al, 2011), or stimulants and vasomodulators such as caffeine (Chen & Parrish, 2009;Koppelstaetter et al, 2010).…”

Investigating resting brain perfusion abnormalities and disease target-engagement by intranasal oxytocin in women with bulimia nervosa and binge-eating disorder and healthy controls

“…Participants were asked to eat 2.5 h prior to each experimental visit, to control for baseline hunger. All participants were tested at approximately the same time in the early evening (5-7 pm) for both the OT and placebo treatments, to minimize potential circadian variability in resting brain activity 55 or OT levels 56 . Fifty minutes after arrival, participants self-administered 40 IU intranasal OT (Syntocinon, 40 IU/ml; Novartis, Basel, Switzerland) in ten puffs, one puff every 30 s, each puff containing 0.1 ml Syntocinon (4 IU) or placebo (same excipients as Syntocinon except for OT) and alternating between nostrils, over a period of 5 min.…”